Items where Author is "Fischer, H."

Yes

Boehringer, M. and Fischer, H. and Hennig, M. and Hunziker, D. and Huwyler, J. and Kuhn, B. and Loeffler, B. M. and Luebbers, T. and Mattei, P. and Narquizian, R. and Sebokova, E. and Sprecher, U. and Wessel, H. P.. (2010) Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors. Bioorganic & medicinal chemistry letters, Vol. 20, H. 3. pp. 1106-1108.

Mattei, P. and Boehringer, M. and Di Giorgio, P. and Fischer, H. and Hennig, M. and Huwyler, J. and Kocer, B. and Kuhn, B. and Loeffler, B. M. and Macdonald, A. and Narquizian, R. and Rauber, E. and Sebokova, E. and Sprecher, U.. (2010) Discovery of carmegliptin : a potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & medicinal chemistry letters, Vol. 20, H. 3. pp. 1109-1113.

Gerebtzoff, G. and Li-Blatter, X. and Fischer, H. and Frentzel, A. and Seelig, A.. (2004) Halogenation of drugs enhances membrane binding and permeation. ChemBioChem, Vol. 5, H. 5. pp. 676-684.

Seelig, A. and Gatlik, E. and Fischer, H. and Li-Blatter, X.. (2003) Towards P-glycoprotein structure-activity relationships. In: Drug bioavailability. Weinheim, pp. 461-492.

Andre, J. P. and Toth, E. and Fischer, H. and Seelig, A. and Macke, H. R. and Merbach, A. E.. (1999) High relaxivity for monomeric Gd(DOTA)-based MRI contrast agents, thanks to micellar self-organization. Chemistry, Vol. 5, no. 10. pp. 2977-2983.

Fischer, H. and Seelig, A. and Beier, N. and Raddatz, P. and Seelig, J.. (1999) New drugs for the Na+/H+ exchanger : Influence of Na+ concentration and determination of inhibition constants with a microphysiometer. The Journal of Membrane Biology, 168 (1). pp. 39-45.

Fischer, H. and Gottschlich, R. and Seelig, A.. (1998) Blood-brain barrier permeation : molecular parameters governing passive diffusion. The Journal of Membrane Biology, 165 (3). pp. 201-211.